# Morbimortality of Covid-19 in Patients With Chronic Inflammatory Rheumatism Treated With Immunosuppressants

> **NCT04426279** · — · TERMINATED · sponsor: **University Hospital, Lille** · enrollment: 539 (actual)

## Conditions studied

- Sars-CoV2
- Rheumatoid Arthritis
- Rheumatic Diseases

## Interventions

- **OTHER:** questionnaire assesment

## Key facts

- **NCT ID:** NCT04426279
- **Lead sponsor:** University Hospital, Lille
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2020-08-18
- **Primary completion:** 2021-03-01
- **Final completion:** 2021-08-30
- **Target enrollment:** 539 (ACTUAL)
- **Why stopped:** Number of patients not reached during the inclusion period, end of funding.
- **Last updated:** 2022-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04426279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04426279, "Morbimortality of Covid-19 in Patients With Chronic Inflammatory Rheumatism Treated With Immunosuppressants". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT04426279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*